The Commerce Commission has published a statement relating to an application from Southern Community Laboratories to acquire 100% of shares in Medlab South.
Both companies provide community and hospital pathology services to various district health boards.
The statement outlines key competition issues that the commission considers will be important in deciding whether or not to allow the merger.
The commission must decide whether the competition lost in a market when two businesses merge is substantial.
